The Children's International Mucositis Evaluation Scale Is Valid and Reliable for the Assessment of Mucositis Among Brazilian Children With Cancer

The Children's International Mucositis Evaluation Scale (ChIMES) is considered a valid and reliable instrument for the assessment of mucositis in pediatric patients aged 0–18 years. To perform the translation and cultural adaptation of ChIMES to Brazilian Portuguese and assess its psychometric...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pain and symptom management 2018-11, Vol.56 (5), p.774-780.e2
Hauptverfasser: Paiva, Bianca Sakamoto Ribeiro, Barroso, Eliane Marçon, Cadamuro, Sandra Andrade, Paula, Lia Alexandre Botelho de, Pirola, William Eduardo, Serrano, Cláudia Valéria Maseti Pimenta, Paiva, Carlos Eduardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Children's International Mucositis Evaluation Scale (ChIMES) is considered a valid and reliable instrument for the assessment of mucositis in pediatric patients aged 0–18 years. To perform the translation and cultural adaptation of ChIMES to Brazilian Portuguese and assess its psychometric properties. Methods for translation and cultural adaptation were used. Other measurements obtained concomitantly for the assessment of psychometric properties included the Oral Mucositis Daily Questionnaire, a visual analog scale, the World Health Organization grading scale for mucositis, and the National Cancer Institute Common Terminology Criteria for Adverse Events toxicity scale. For test-retest analysis, patients and guardians responded to the self-report and proxy versions of ChIMES within intervals of one to seven days. Regarding internal consistency, Cronbach's alpha (α) values were 0.769 (95% CI = 0.631–0.868) and 0.879 (95% CI = 0.872–0.920) for the self-reported and proxy versions, respectively. The convergent validity criteria were met for the self-reported and proxy versions (Spearman's rho = 0.466–0.751; P 
ISSN:0885-3924
1873-6513
DOI:10.1016/j.jpainsymman.2018.07.015